FIRAS AKHRASS: Open Payments
NPI 1487636205 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184,189 in 555 payments from 33 companies in 2025. Trend: 2023 $115,682 · 2024 $134,369 · 2025 $184,189
Speaker / faculty: $118,867Honoraria: $25,095Consulting: $16,035Travel & lodging: $12,313Food & beverage: $11,794Education: $85
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 68 | $52,012 |
| Madrigal Pharmaceuticals | 66 | $47,388 |
| Novo Nordisk Inc | 43 | $35,111 |
| Xeris Pharmaceuticals, Inc. | 34 | $19,804 |
| Lilly USA, LLC | 47 | $19,762 |
| CeQur Corporation | 2 | $2,518 |
| Mannkind Corporation | 18 | $2,071 |
| Sequel Med Tech, LLC | 47 | $932 |
| Dexcom, Inc. | 17 | $560 |
| Ascensia Diabetes Care Us Inc. | 18 | $481 |
Products named: Korlym, REZDIFFRA, Ozempic, RECORLEV, MOUNJARO, CeQur Simplicity, AFREZZA, TWIIST.
Industry payments across TX — which companies pay providers there.
